Drug Delivery: Injection Devices
Drug Delivery: Injection Devices
$4,750.00
Despite its relative invasiveness and technological maturity, instrument-based injection of pharmaceutical preparations is commonly regarded as the most accurate, effective, reliable, and reproducible method of therapeutic drug and fluid delivery. In 2021, combined sales of the injection devices covered by this report totaled nearly $5.7bn.
Publisher: Meddevicetracker
- Highlights
- Description
- Contents
Executive Summary
This medical market and technology report provides a comprehensive discussion of injection drug delivery technology, including the syringes market and the vascular access devices (VADs) market.
The syringes market consists of:
- standard needles/syringes
- safety needles/syringes.
The VADs market consists of:
- short peripheral catheters (SPCs)
- midline catheters
- peripherally inserted central catheters (PICCs)
- central venous catheters (CVCs)
- implantable ports.
Overview
Despite its relative invasiveness and technological maturity, instrument-based injection of pharmaceutical preparations is commonly regarded as the most accurate, effective, reliable, and reproducible method of therapeutic drug and fluid delivery. In 2021, combined sales of the injection devices covered by this report totaled nearly $5.7bn. Market drivers include legislative changes requiring the use of safety devices to help prevent needlestick injury, continuing growth in the volume of outpatient infusion procedures relying on more costly longer-term VADs, and an ongoing transition to premium-priced safety catheters in hospitals and alternate care facilities. Market limiters include the development of drug delivery methods that do not involve skin puncture (eg inhalation therapy products, oral medications, and transdermal patches). This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global markets for injection-based drug delivery devices; these include standard and safety needles/syringes, and vascular access devices (short peripheral catheters, midline catheters, PICCs, CVCs, and implantable ports). Countries covered by this report include the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of World. The forecast range for this report is 2021–26.
The report provides the following useful information:
- an overview of injection drug delivery technology
- related product portfolios offered by leading manufacturers
- top selling injection drug delivery devices, as well as emerging products under development
- in-depth market and competitive analyses.
Table of Contents
Executive Summary …………………………………………………………………….. ES-1
i. Needles and syringes market…………………………………………………………………………….. ES-2
ii. Vascular access devices market………………………………………………………………………… ES-3
iii. Selected market drivers and limiters…………………………………………………………………. ES-5
iv. Market leaders……………………………………………………………………………………………… ES-6
v. Methodology…………………………………………………………………………………………………. ES-6
Exhibit ES-1: Injection drug delivery devices, combined market forecast ($m), 2021–26………………………………………………………………………………………….. ES-2
1. Injection Devices ……………………………………………………………………….1-1
1.1 Overview……………………………………………………………………………………………………….1-1
1.2 Needlestick injury……………………………………………………………………………………………1-1
1.3 Regulations and guidelines……………………………………………………………………………….1-2
1.4 Standard disposable needles and syringes…………………………………………………………..1-3
1.4.1 Market analysis…………………………………………………………………………………1-4
1.4.2 Competitive analysis………………………………………………………………………….1-6
1.5 Safety needles and syringes…………………………………………………………………………….1-10
1.5.1 Market analysis……………………………………………………………………………….1-11
1.5.2 Competitive analysis………………………………………………………………………..1-13
1.6 Combined market forecast……………………………………………………………………………..1-15
1.7 Bibliography…………………………………………………………………………………………………1-17
Exhibit 1-1: Standard disposable needles and syringes, market forecast, by region ($m), 2021–26 ………………………………………………………………………1-5
Exhibit 1-2: Becton Dickinson, revenues by segment, FY2021………………………………………1-7
Exhibit 1-3: Cardinal Health, revenues by segment, FY2021…………………………………………1-8
Exhibit 1-4: Smiths Group, revenues by segment, FY2021 …………………………………………..1-9
Exhibit 1-5: Standard disposable needles and syringes market, share by supplier, 2021 …1-10
Exhibit 1-6: Safety needles and syringes, market forecast, by region ($m), 2021–26………1-12
Exhibit 1-7: Safety needles and syringes market, share by supplier, 2021…………………….1-15
Exhibit 1-8: Injection devices, combined market forecast, by product type ($m), 2021–26 ……………………………………………………………1-16
2. Vascular Access Devices………………………………………………………………2-1
2.1 Short peripheral catheters………………………………………………………………………………..2-3
2.1.1 Products ………………………………………………………………………………………….2-3
2.1.2 Market analysis…………………………………………………………………………………2-4
2.1.3 Competitive analysis………………………………………………………………………….2-5
2.2 Midline catheters……………………………………………………………………………………………2-8
2.2.1 Products ………………………………………………………………………………………….2-9
2.2.2 Market analysis…………………………………………………………………………………2-9
2.2.3 Competitive analysis………………………………………………………………………..2-10
2.3 Peripherally inserted central catheters……………………………………………………………..2-12
2.3.1 Products ………………………………………………………………………………………..2-13
2.3.2 Market analysis……………………………………………………………………………….2-13
2.3.3 Competitive analysis………………………………………………………………………..2-14
2.4 Central venous catheters………………………………………………………………………………..2-15
2.4.1 Products ………………………………………………………………………………………..2-16
2.4.2 Market analysis……………………………………………………………………………….2-17
2.4.3 Competitive analysis………………………………………………………………………..2-18
2.5 Implantable ports………………………………………………………………………………………….2-20
2.5.1 Products ………………………………………………………………………………………..2-21
2.5.2 Market analysis……………………………………………………………………………….2-21
2.5.3 Competitive analysis………………………………………………………………………..2-23
2.6 Combined market forecast……………………………………………………………………………..2-25
2.7 Bibliography…………………………………………………………………………………………………2-27
Exhibit 2-1: Infection risk of vascular access devices…………………………………………………..2-2
Exhibit 2-2: Short peripheral catheters, market forecast, by region ($m), 2021–26………….2-5
Exhibit 2-3: Becton Dickinson, revenues by segment, FY2021………………………………………2-6
Exhibit 2-4: Smiths Group, revenues by segment, FY2021 …………………………………………..2-7
Exhibit 2-5: Short peripheral catheters market, share by supplier, 2021………………………..2-8
Exhibit 2-6: Midline catheters, market forecast, by region ($m), 2021–26 ……………………2-10
Exhibit 2-7: AngioDynamics, revenues by segment, FY2021……………………………………….2-11
Exhibit 2-8: Midline catheters market, share by supplier, 2021 ………………………………….2-12
Exhibit 2-9: Peripherally inserted central catheters, market forecast, by region ($m), 2021–26 …………………………………………………………………….2-14
Exhibit 2-10: Peripherally inserted central catheters market, share by supplier, 2021 ……2-15
Exhibit 2-11: Central venous catheters, market forecast, by region ($m), 2021–26………..2-18
Exhibit 2-12: Teleflex Medical, revenues by segment, FY2021 ……………………………………2-19
Exhibit 2-13: Central venous catheters market, share by supplier, 2021 ………………………2-20
Exhibit 2-14: Implantable ports, market forecast, by region ($m), 2021–26………………….2-23
Exhibit 2-15: Implantable ports market, share by supplier, 2021 ………………………………..2-24
Exhibit 2-16: Vascular access devices, combined market forecast ($m), 2021–26 ………….2-26
3. Appendix: Company Listing ………………………………………………………… A-1
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Chronic Lymphocytic Leukemia (CLL) KOL Interview – US, South #1 
Sign up to the